一个表观遗传上不同的HSC子集支持胸膜重构
bioRxiv : the preprint server for biology
|June 19, 2024
概括
血造干细胞 (HSC) 具有增强的淋巴细胞潜力,可改善移植后的T细胞恢复. 这种Kitlo HSC子集随着年龄的增长而下降,但可以通过Zbtb1进行调节,以获得更好的免疫复合.
科学领域:
- 免疫学 免疫学 免疫学
- 干细胞生物学 干细胞生物学
- 血液形成 血液形成 血液形成
背景情况:
- 造血干细胞 (HSC) 在异种造血干细胞移植 (allo-HCT) 后对免疫系统恢复至关重要.
- HSCs的Kitlo子集显示出对多能前体活性有希望.
- 基特lo HSCs的T细胞谱系潜力仍然不完全理解.
研究的目的:
- 调查基特lo HSCs. 的胸膜重构和T细胞潜力.
- 探索Kitlo HSCs在与年龄相关的免疫衰退和T细胞恢复中的作用.
- 阐明分子机制,包括转录因子活性,控制 Kitlo HSC 淋巴细胞潜力.
主要方法:
- 利用临床前的 allo-HCT 模型来评估胸膜和T细胞恢复.
- 分析了 Kitlo HSCs 在老年小鼠和年轻小鼠中的频率和功能.
- 进行了染色体分析,以确定关键的转录因子 (TF) 和基因调控网络.
- 在HSC子集中基因操纵Zbtb1表达,以评估其对T细胞潜力的 in vitro和 in vivo 影响.
主要成果:
- 基特lo HSCs在合HCT后表现出优异的胸膜恢复和T细胞复合,导致增强的T细胞反应.
- 这些HSC减轻了与年龄相关的胸膜变化,改善了中年宿主T细胞的恢复.
- 基特lo HSC 的频率随着年龄的增长而下降,与降低的T-淋巴细胞潜力相关.
- 染色体分析显示,在Kitlo HSC中,淋巴细胞特异性TFs,特别是Zbtb1的活性增加.
- 删除Zbtb1损害了T细胞的潜力,而其重新引入Kit HSCs则恢复了它.
- 确定了一个类似的人类KITlo HSC子集,具有增强的淋巴细胞潜力.
结论:
- HSCs拥有独特的表观遗传程序,可以增强淋巴细胞潜力和T细胞重组.
- 基特loHSC频率与年龄相关的下降有助于老年人T细胞免疫力受损.
- Zbtb1是HSC淋巴细胞系特征和T细胞潜力的关键调节者.
- 准基特lo HSCs及其相关表观遗传调节剂提供了一种有前途的策略,以改善allo-HCT后的免疫复合.
相关概念视频
Multipotency of Hematopoietic Stem Cells
3.1K
The hematopoietic stem cells or HSCs are multipotent, meaning they can differentiate and give rise to all blood and immune cells. HSCs are maintained in the quiescent stage until an external stimulus initiates their differentiation. The multipotent HSCs exist as two heterogeneous populations, long-term repopulating cells (LTRC) and short-term repopulating cells (STRC). The two HSC populations have different surface markers or receptors and are classified based on quiescence and long-term...
3.1K
Regulation of Hematopoietic Stem Cells
3.2K
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
3.2K
Cells of the Adaptive Immune Response
979
The T and B lymphocytes of the adaptive immune system develop from common lymphoid progenitor cells in the bone marrow. These progenitors give rise to precursors that eventually develop into both T and B lymphocytes. As these precursors mature, they gain the ability to detect and respond to foreign antigens in the body, a process known as immunocompetence. Additionally, these precursors acquire self-tolerance, a process that ensures they do not react to self-antigens. This intricate system...
979
Lineage Commitment
3.0K
Commitment is the process whereby stem cells:
3.0K
Production of Formed Elements
1.4K
Hemangioblasts are multipotent stem cells originating from the mesoderm. They give rise to hematopoietic stem cells (HSCs), which undergo hematopoiesis to produce all the formed elements of blood. This process is regulated by a complex network of hematopoietic growth factors, including transcription factors, growth factors, and cytokines. These factors stimulate the HSCs to divide and differentiate, though some HSCs remain undifferentiated to maintain a self-renewing pool.
Most HSCs commit to...
Most HSCs commit to...
1.4K
Hematopoiesis
5.2K
The process of blood cell formation is called hematopoiesis. Hematopoiesis starts early during development, on the seventh day of embryogenesis. This phase of hematopoiesis is called the primitive wave, wherein the extraembryonic yolk sac allows the production of erythroid cells and endothelial cells from a common precursor called hemangioblast. The erythroid cells provide oxygen to support the growth of the rapidly dividing embryo. Hemangioblasts later develop into hematopoietic stem cells or...
5.2K


